SCHEMBL21455445

SCHEMBL21455445

CCOC(=O)Cc1ccc(CC)cc1OF

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 3/20 0.40
▸ HDAC4 P56524 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ CYP4Z1 Q86W10 1/20 0.39
▸ CYP4F2 P78329 1/20 0.39
▸ CYP4A11 Q02928 1/20 0.39
▸ EGFR P00533 1/20 0.38
▸ MAPT P10636 1/20 0.37
▸ DPP4 P27487 2/20 0.37
▸ TBXAS1 P24557 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ GABRA1 P14867 1/20 0.36
▸ GABRB2 P47870 1/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30011105 0.87 DPP4 (0.46) DPP4KMT2ATDP1NFKB1SMN1; SMN2
SCHEMBL21437959 0.87 DPP4 (0.46) DPP4KMT2ATDP1NFKB1SMN1; SMN2
SCHEMBL24199952 0.85 NLRP3 (0.41) PKMEGFRMAPTDPP4TBXAS1
Hexane SCHEMBL31090092 0.82 PPARG (0.45) DPP4
Hexane SCHEMBL21439434 0.82 PPARG (0.45) DPP4
SCHEMBL25883697 0.81 PKM (0.43) PKMHDAC4HDAC6CYP4Z1CYP4F2
SCHEMBL30010570 0.80 TRPA1 (0.47) PKMCYP4Z1CYP4F2CYP4A11EGFR
SCHEMBL21437511 0.80 TRPA1 (0.47) PKMCYP4Z1CYP4F2CYP4A11EGFR
SCHEMBL27693821 0.79 L3MBTL1 (0.43) PKMCYP4Z1CYP4F2CYP4A11EGFR
SCHEMBL31063213 0.78 DPP4 (0.46) DPP4KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019195720-A1 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2019-10-10 — — WO disclosed
Send feedback